Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 6;8(23):5918-5925.
doi: 10.12998/wjcc.v8.i23.5918.

Preliminary analysis of the effect of vagus nerve stimulation in the treatment of children with intractable epilepsy

Affiliations

Preliminary analysis of the effect of vagus nerve stimulation in the treatment of children with intractable epilepsy

Tie Fang et al. World J Clin Cases. .

Abstract

Background: Implant vagus nerve stimulation is an adjunctive treatment for intractable epilepsy when patients are not suitable for resective surgery.

Aim: To identify the safety and efficacy of vagus nerve stimulation in children with intractable epilepsy and analyze the effects on different epilepsy syndromes.

Methods: Eligible children with intractable epilepsy were admitted to the study. We collected data from preoperative assessments as the baseline. During the follow-up time, we recorded the process of seizures (frequency, duration, and seizure type), the changes of drugs or parameters, the complications, etc. The mean reduction rate of seizures, response rate, and McHugh scale were chosen as the outcomes.

Results: A total of 213 patients were implanted with Tsinghua Pins vagus nerve stimulators, and the average age was 6.6 years. In the follow-up time of postoperative 3 mo, 6 mo, 12 mo, 18 mo, and 24 mo, the average reduction rate was 30.2%, 49.5%, 56.3%, 59.4%, and 63.2%, while the response rate was 21.8%, 62.5%, 57.1%, 69.2%, and 70.7%. In addition, implanted vagus nerve stimulation had different effects on epilepsy syndromes. The reduction rate of West syndrome increased from 36.4% (postoperative 6 m) to 74.3% (postoperative 24 m). The reduction rate of Lennox-Gastaut syndrome improved from 25.4% to 73.1% in 24 mo. The chi-square test of the five efficacy grades showed P < 0.05. The comparison between the 3-mo follow-up and the 6-mo follow-up showed P < 0.05, and the comparison between the 6-mo follow-up and the 24-mo follow-up showed P > 0.05.

Conclusion: Vagus nerve stimulation is safe and effective in children with intractable epilepsy, and the seizure reduction occurred in a time-dependent manner. Moreover, patients with West syndrome may get the most benefits.

Keywords: Children; Epilepsy syndrome; Intractable epilepsy; Operation; Stimulation; Vagus nerve.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Average attack reduction rate.
Figure 2
Figure 2
Probability of treatment.
Figure 3
Figure 3
McHugh classification.

Similar articles

Cited by

References

    1. Panebianco M, Bresnahan R, Ramaratnam S, Marson AG. Lamotrigine add-on therapy for drug-resistant focal epilepsy. Cochrane Database Syst Rev. 2020;3:CD001909. - PMC - PubMed
    1. Liu C, Wen XW, Ge Y, Chen N, Hu WH, Zhang T, Zhang JG, Meng FG. Responsive neurostimulation for the treatment of medically intractable epilepsy. Brain Res Bull. 2013;97:39–47. - PubMed
    1. Moro-De Faes G, Serrano-Moyano B, Cantarin-Extremera V, Moreno-Vinues B, Garcia-Fernandez M, Perez-Jimenez MA, Rivero-Martin MB, Garcia-Ezquiaga J, Duat-Rodriguez A, Ruiz-Falco Rojas ML. [Ten years' experience with vagus nerve stimulation in a paediatric population] Rev Neurol. 2018;67:382–386. - PubMed
    1. Kun Y, Zejun D, Jian Z, Feng Z, Changqing L, Xueling Q. Surgical histopathologic findings of 232 Chinese children cases with drug-resistant seizures. Brain Behav. 2020;10:e01565. - PMC - PubMed
    1. Uchida D, Yamamoto T, Yamazoe T, Iijima K, Fujimoto A, Enoki H, Tanaka T. [Experience and Solution of Complications of Vagus Nerve Stimulation Therapy in 139 Implant Patients with Medically Refractory Epilepsy] No Shinkei Geka. 2017;45:1051–1057. - PubMed